Investor Notice: Robbins LLP Informs Investors of the GeneDx Holdings Corp. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)---- $WGS #Biogenetics--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired GeneDx Holdings Corp. (NASDAQ: WGS) common stock between April 16, 2025 and May 4, 2026. GeneDx Holdings Corp is a genomics company that provides genetic testing services for diagnosing pediatric and rare diseases. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbin.